Bupropion Toxicity Presenting As Alcohol Withdrawal Syndrome: A Case Report. [PDF]
Nguyen D +3 more
europepmc +1 more source
Identifying Predictors of Weight-Related Outcomes With Fixed-Dose, Extended-Release Naltrexone and Bupropion Among Treatment-Adherent Patients in Phase 3 COR Trials: A Treatment Target Analysis. [PDF]
Ryan DH +5 more
europepmc +1 more source
Treatment patterns and comparative clinical outcomes of ADHD medications in adolescents and young adults with comorbid major depressive disorder. [PDF]
Baweja R +6 more
europepmc +1 more source
Design of INFORMUS, a pragmatic, randomized, double-blind, placebo-controlled study of cardiovascular outcomes with the extended-release, fixed-dose combination of naltrexone and bupropion. [PDF]
Kyle M +3 more
europepmc +1 more source
Task-aligned outcome learning in psychiatry: reducing endpoint dilution. [PDF]
Strobl EV.
europepmc +1 more source
Utilization and adherence to smoking cessation pharmacotherapy: A population-based study in Spain. [PDF]
Majo García R +5 more
europepmc +1 more source
Circulating Polyamines and Metabolic Changes Following a Mediterranean Diet with or Without Naltrexone/Bupropion in Breast Cancer Survivors: An Exploratory Secondary Analysis. [PDF]
Choi WJ +6 more
europepmc +1 more source
One-year comparative effectiveness of bupropion and nicotine replacement therapy in smoking cessation: A prospective observational cohort study in Turkey. [PDF]
Koksal NG, Koksal M.
europepmc +1 more source
Real-world effectiveness of cytisine, bupropion, and nicotine replacement therapy in a smoking cessation clinic: A single-center retrospective cohort study. [PDF]
Aksoy HB.
europepmc +1 more source
Dextromethorphan-bupropion combination in depression with dual diagnosis: Insights from a case series. [PDF]
Aggarwal M +4 more
europepmc +1 more source

